- ATNF Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
-
8-K Filing Data
180 Life Sciences (ATNF) 8-K15 Nov 22Adalimumab Found To Be a Likely Cost-Effective Treatment for Early-Stage Dupuytren’s DiseaseFinancial data
Company Profile